drugset
drugset / Trial / NCT02576366

Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus

NCT02576366 ↗

Phase 4 Completed 24 enrolled Universitaire Ziekenhuizen KU Leuven
Non-randomizedCrossoverOpen-labelDiagnostic

Summary

Single center, open label crossover study with 2 treatment phases in healthy volunteers. The potential of phenotypic drug probes to predict drug-drug interactions between tacrolimus, voriconazole and rifampin will be assessed.

Timeline

Start
2016-06
Primary completion
2017-05
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Rifampin Small molecule 600 mg Oral
Subject Voriconazole Small molecule 200 mg Oral

Indications

No indication recorded.